UNFAVORABLE PROGNOSTIC VALUE OF BCR-ABL1-LIKE IS INDEPENDENT OF AN INTEGRATED GENETIC RISK SCORE IN PEDIATRIC BCP-ALL

被引：0
|
作者：
Boer, J. M. [1 ]
Escherich, G. [2 ]
de Groot-Kruseman, H. A. [3 ]
Pieters, R. [3 ,4 ]
den Boer, M. L. [1 ]
机构：
[1] Erasmus MC Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands
[2] German Cooperat Study Grp Childhood Acute Lymphob, COALL, Hamburg, Germany
[3] Dutch Childhood Oncol Grp, DCOG, The Hague, Netherlands
[4] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P527
引用
收藏
页码：197 / 198
页数：2
相关论文
共 33 条
  • [21] Outcomes of Children With BCR-ABL1-Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease
    Roberts, Kathryn G.
    Pei, Deqing
    Campana, Dario
    Payne-Turner, Debbie
    Li, Yongjin
    Cheng, Cheng
    Sandlund, John T.
    Jeha, Sima
    Easton, John
    Becksfort, Jared
    Zhang, Jinghui
    Coustan-Smith, Elaine
    Raimondi, Susana C.
    Leung, Wing H.
    Relling, Mary V.
    Evans, William E.
    Downing, James R.
    Mullighan, Charles G.
    Pui, Ching-Hon
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3012 - +
  • [22] EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications
    Schwab, Claire
    Ryan, Sarra L.
    Chilton, Lucy
    Elliott, Alannah
    Murray, James
    Richardson, Stacey
    Wragg, Christopher
    Moppett, John
    Cummins, Michelle
    Tunstall, Oliver
    Parker, Catriona A.
    Saha, Vaskar
    Goulden, Nicholas
    Vora, Ajay
    Moorman, Anthony V.
    Harrison, Christine J.
    BLOOD, 2016, 127 (18) : 2214 - 2218
  • [23] Leukemia Cells with a BCR-ABL1-Like signature and/or IKZF1 deletions, but Not High CRLF2 Expression, Are Predictive of an Unfavorable Prognosis in Childhood B Cell Precursor Acute Lymphoblastic Leukemia
    Van Der Veer, Arian
    Waanders, Esmee
    Pieters, Rob
    Willemse, Marieke E.
    Reijmersdaal, Simon
    Russell, Lisa J.
    Harrison, Christine J.
    Evans, William E.
    van der Velden, Vincent H. J.
    Hoogerbrugge, Peter M.
    van Leeuwen, Frank N.
    Escherich, G.
    Horstman, Martin
    Khankandani, Leila Mohamadi
    Rizopoulos, Dimitris
    de Groot-Kruseman, Hester A.
    Sonneveld, Edwin
    Kuiper, Roland P.
    Den Boer, Monique L.
    BLOOD, 2012, 120 (21)
  • [24] Prognostic Impact of Concurrent BCR/ABL1 Gene Rearrangement on Survival Outcome in Ph-like B-ALL Patients
    Yun, Seongseok
    Vincelette, Nicole D.
    Lancet, Jeffrey E.
    Chavez, Julio C.
    Shah, Bijal D.
    Zhang, Ling
    BLOOD, 2017, 130
  • [25] Outcome of Children with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) with Hypodiploidy or BCR-ABL1 Fusion Given Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Results from the Prospective Forum Study
    Buechner, Jochen
    Poetschger, Ulrike
    Kurzmann, Paulina
    Bader, Peter
    Dalle, Jean-Hugues
    Yesilipek, Akif
    Pichler, Herbert
    Palma, Julia
    Staciuk, Raquel
    Sedlacek, Petr
    Krivan, Gergely
    Ifversen, Marianne
    Gungor, Tayfun
    Rousou, Vassiliki Kitra
    Kalwak, Krzysztof
    Toporski, Jacek
    Shaw, Peter J.
    Renard, Marleen
    Diaz De Heredia, Cristina
    Matic, Toni
    Bierings, Marc
    Svec, Peter
    Meisel, Roland
    Balduzzi, Adriana
    Locatelli, Franco
    Peters, Christina
    Stein, Jerry
    BLOOD, 2023, 142
  • [26] THE INCIDENCE OF THE HIGH-RISK PH-LIKE ALL SUBTYPE MAY ACCOUNT FOR THE MAJORITY OF NON BCR-ABL1+B ALL CASES IN ADULTS
    Nievergall, E.
    Heatley, S.
    Kok, C.
    Dang, P.
    Frede, A.
    Moore, S.
    Roberts, K.
    Yeung, D.
    Hughes, T.
    Mullighan, C.
    White, D.
    HAEMATOLOGICA, 2014, 99 : 239 - 240
  • [27] BCR::ABL1-Positive Acute Lymphoblastic Leukemia: Different Clinical Behavior and Relevance of Prognostic Features in Typical ALL and in CML-like Disease
    Zuna, Jan
    Hovorkova, Lenka
    Krotka, Justina
    Koehrmann, Amelie
    Bardini, Michela
    Winkowska, Lucie
    Fronkova, Eva
    Alten, Julia
    Koehler, Rolf
    Eckert, Cornelia
    Brizzolara, Lisa
    Stuchly, Jan
    Zimmermann, Martin
    De Lorenzo, Paola
    Valsecchi, Maria Grazia
    Conter, Valentino
    Stary, Jan
    Schrappe, Martin
    Biondi, Andrea
    Trka, Jan
    Zaliova, Marketa
    Cazzaniga, Giovanni
    Cario, Gunnar
    BLOOD, 2022, 140 : 9179 - 9180
  • [28] The frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India
    Sharma, Praveen
    Rana, Sonia
    Virk, Harpreet
    Sachdeva, Man Updesh Singh
    Sharma, Prashant
    Varma, Neelam
    Jain, Richa
    Bansal, Deepak
    Trehan, Amita
    Khadwal, Alka Rani
    Malhotra, Pankaj
    Sreedharanunni, Sreejesh
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2474 - 2478
  • [29] Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like ("Ph-like" or "BCR-ABL1-Like") Signature For Therapeutic Targeting and Clinical Intervention
    Harvey, Richard C.
    Kang, Huining
    Roberts, Kathryn G.
    Chen, I-Ming L.
    Atlas, Susan R.
    Bedrick, Edward J.
    Gastier-Foster, Julie M.
    Zhang, Jinghui
    Gerhard, Daniels S.
    Smith, Malcolm A.
    Larsen, Eric C.
    Raetz, Elizabeth A.
    Winick, Naomi J.
    Carroll, William L.
    Stonerock, Eileen
    Heerema, Nyla A.
    Carroll, Andrew J.
    Chen, Shann-Ching
    Song, Guangchun
    Becksfort, Jared
    Rusch, Michael
    Li, Yongjin
    Ma, Jing
    Ell, Denise
    Reshmi, Shalini C.
    Loh, Mignon L.
    Davidas, Meenakshi
    Hunger, Stephen P.
    Mullighan, Charles G.
    Willman, Cheryl L.
    BLOOD, 2013, 122 (21)
  • [30] PREDICTIVE VALUE OF IG/TR AND BCR/ABL1 PCR-BASED MINIMAL RESIDUAL DISEASE MONITORING IN PH plus PEDIATRIC ALL TREATED WITH IMATINIB IN THE ESPHALL STUDY
    Cazzaniga, G.
    De Lorenzo, P.
    Alten, J.
    Roettgers, S.
    Hancock, J.
    Saha, V.
    Castor, A.
    Madsen, H.
    Gandemer, V.
    Cave, H.
    Leoni, V.
    Ferrari, G.
    Pieters, R.
    van der Velden, V.
    Stary, J.
    Zuna, J.
    Escherich, G.
    zur Stadt, U.
    Arico, M.
    Conter, V.
    Schrappe, M.
    Valsecchi, M. G.
    Biondi, A.
    HAEMATOLOGICA, 2016, 101 : 358 - 358
1234